期刊文献+

氧化甾醇受体(LXRs)配体的合成 被引量:1

原文传递
导出
摘要 以猪去氧胆酸甲酯4为原料,乙酰链甾醇11为关键中间体和改进的Sharpless不对称双羟化反应为关键步骤,经9步反应,以56%的总收率和100%de高立体选择性地合成了LXRs激动剂24S,25-环氧胆固醇1.并通过1合成了LXRα亚型选择性激动剂5α,6α:24S,25-双环氧胆固醇2以及新配体5β,6β24S,25-双环氧胆固醇3.
出处 《科学通报》 EI CAS CSCD 北大核心 2002年第24期1868-1875,共8页 Chinese Science Bulletin
基金 国家自然科学基金(批准号:20072047) 中国科学院上海有机化学研究所生命有机化学国家重点实验室基金 第三军医大学科研基金资助项目 重庆市攻关项目(批准号:6617).
  • 相关文献

参考文献28

  • 1吴葆杰. 抗动脉粥样硬化药的进展情况. 见: 金正均, 汪永铭, 苏定冯主编. 药理学进展. 北京: 科学出版社, 1998. 96-99
  • 2Ferber D. Possible new way to lower cholesterol. Science, 2000, 289: 1446-1447
  • 3Kliewer S A, Lehmann J M, Willson T M. Orphan nuclear receptors: Shifting endocrinology into reverse. Science, 1999, 284: 757~760
  • 4Apfel R, Benbrook D, Lernhardt E, et al. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily. Mol Cell Biol, 1994, 14: 7025~7035
  • 5Willy P J, Umesono K, Ong E S, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev, 1995, 9: 1033~1045
  • 6Song C, Hiipakka R A, Kokontis J M, et al. Ubiquitous receptor: structures, immunocytochemical localization, and modulation of gene activation by receptors for retinoic acids and thyroid hormones. Ann N Y Acad Sci, 1995, 761: 38~49
  • 7Lehman J M, Kliewer S A, Moore L B, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem, 1997, 272: 3137~3140
  • 8Peet D J, Turley D, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR(. Cell, 1998, 93: 693~704
  • 9Luo Y, Tall A R. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest, 2000, 105(4): 513~520
  • 10Repa J J, Turley S D, Lobaccaro J -M A, et al. Regulation of absorption and ABC1-Mediated efflux of cholesterol by RXR heterodimers. Science, 2000, 289: 1524~1529

同被引文献24

  • 1Ercoli A, de-Ruggieri P. The constitution of cerebrosterol, a hydroxycholesterol isolated from horse brain[J]. J Am Chem Soc, 1953, 75(13): 3284. DOI: 10.1021/ja01109a515.
  • 2Di-Frisco S, De-Ruggieri P, Ercoli A. Isolation of cerebrosterol from human brain[J]. Boll Soc Ital Biol Sper, 1953, 29(7): 1351-1352.
  • 3Dhar A K, Teng J I, Smith L L. Biosynthesis of cholest-5-ene-3beta, 24-diol (cerebrosterol) by bovine cerebral cortical microsomes[J]. J Neurochem, 1973, 21(1): 51-60. DOI: 10.1111/j.1471-4159.1973.tb04224.x.
  • 4Bjorkhem I, Cedazo-Minguez A, Leoni V, et al. Oxysterols and neurodegenerative diseases[J]. Mol Aspects Med, 2009, 30(3): 171-179. DOI: 10.1016/j.mam.2009.02.001.
  • 5Gosselet F, Saint-Pol J, Fenart L. Effects of oxysterols on the blood-brain barrier: implications for Alzheimer's disease[J]. Biochem Biophys Res Commun, 2014, 446(3): 687-691. DOI: 10.1016/j.bbrc.2013.11.059.
  • 6Schonknecht P, Lutjohann D, Pantel J, et al. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer’s disease compared to healthy controls[J]. Neurosci Lett, 2002, 324(1): 83-85. DOI: 10.1016/S0304-3940(02)00164-7.
  • 7Bjorkhem I, Lovgren-Sandblom A, Leoni V, et al. Oxysterols and Parkinson's disease: evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease[J]. Neurosci Lett, 2013, 555: 102-105. DOI: 10.1016/j.neulet.2013.09.003.
  • 8Leoni V, Long J D, Mills J A, et al. Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression[J]. Neurobiol Dis, 2013, 55: 37-43. DOI: 10.1016/j.nbd.2013.03.013.
  • 9Leoni V, Caccia C. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases[J]. Biochimie, 2013, 95(3): 595-612. DOI: 10.1016/j.biochi.2012.09.025.
  • 10Noguchi N, Saito Y, Urano Y. Diverse functions of 24(S)-hydroxycholesterol in the brain[J]. Biochem Biophys Res Commun, 2014, 446(3): 692-696. DOI: 10.1016/j.bbrc.2014.02.010.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部